Ragaglitazar是一种PPARα和PPARγ激动剂,在动物模型中具有有效的降脂和胰岛素增敏作用。Ragaglitazar可改善2型糖尿病患者的血糖控制和血脂水平。
生物活性 | Ragaglitazar is aPPARαandPPARγagonist with potent lipid-lowering and insulin-sensitizing efficacy in animal models. Ragaglitazar improves glycemic control and lipid profile in type 2 diabetic. |
分子量 | |
Formula | |
CAS 号 | |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |